Cargando…

Coronary pseudoaneurysm 1 week after complex percutaneous coronary intervention with drug‐eluting stent

Pseudoaneurysm formation is a rare complication after complex PCI with drug‐eluting stents. Cardiologists and interventionist should be familiar with this rare complication after PCI and its management options.

Detalles Bibliográficos
Autores principales:	Namazi, Mohammad Hasan, Khani, Mohammad, Faghihi Langroudi, Taraneh, Abedi, Fatemeh, Tabary, Mohammadreza, Khaheshi, Isa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364079/ https://www.ncbi.nlm.nih.gov/pubmed/32695378 http://dx.doi.org/10.1002/ccr3.2910

Ejemplares similares

Double orifice mitral valve in a patient with bicuspid aortic valve and coarctation of the aorta: A rare presentation
por: Bayat, Fariba, et al.
Publicado: (2020)

Stent underexpansion in angiographic guided percutaneous coronary intervention, despite adjunctive balloon post-dilatation, in drug eluting stent era
por: Taherioun, Mehrdad, et al.
Publicado: (2014)

The Association between the Pulmonary Arterial Obstruction Index and Atrial Size in Patients with Acute Pulmonary Embolism
por: Faghihi Langroudi, Taraneh, et al.
Publicado: (2019)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Evaluation of pentraxin-3 level and its related factors in patients undergoing primary percutaneous coronary intervention
por: Alipour-Parsa, Saeed, et al.
Publicado: (2017)

Prognostic implications of biventricular strain measurement in COVID‐19 patients by speckle‐tracking echocardiography
por: Khani, Mohammad, et al.
Publicado: (2021)

One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2016)

Is it necessary to discontinue metformin in diabetic patients with GFR > 60 ml/min per 1.73 m(2) undergoing coronary angiography: A controversy still exists?
por: Namazi, Mohammad Hasan, et al.
Publicado: (2018)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials
por: Alazzoni, Ashraf, et al.
Publicado: (2012)

Unusual Presentation of a Rapidly Progressive Coronary Artery Pseudoaneurysm after Drug Eluting Stent Placement
por: Reddy, Sreenivas, et al.
Publicado: (2021)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
por: Panoulas, Vasileios F, et al.
Publicado: (2015)

Adverse Cardiovascular Outcomes associated with Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention with Everolimus Eluting Stents: A Meta-Analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

Percutaneous coronary intervention for coronary allograft vasculopathy with drug-eluting stent in Indian subcontinent: Issues in diagnosis and management
por: Alam, Mohammed Shakawat, et al.
Publicado: (2020)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
por: Zhu, Yong, et al.
Publicado: (2021)

Risk of non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents
por: Park, Sun-Kyung, et al.
Publicado: (2017)

Newer-Generation Drug-Eluting Stents in Patients Undergoing Complex Percutaneous Coronary Intervention
por: Otsuka, Kenichiro
Publicado: (2021)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Koni, Endrin, et al.
Publicado: (2021)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Immediate Results and Six-Month Clinical Outcome after Percutaneous Coronary Intervention in Patients with Prior Coronary Artery Bypass Surgery
por: Behboudi, Fatemeh, et al.
Publicado: (2011)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Fractured coronary stent with mycotic pseudoaneurysm and abscess
por: Kumar, Naveen, et al.
Publicado: (2022)

Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
por: Baschet, Louise, et al.
Publicado: (2016)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Pentraxin 3 Is Highly Specific for Predicting Anatomical Complexity of Coronary Artery Stenosis as Determined by the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score
por: Namazi, Mohammad Hasan, et al.
Publicado: (2014)

The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention(*)
por: Jazi, Seyed Mohammad Hashemi, et al.
Publicado: (2011)

Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis
por: Meng, Min, et al.
Publicado: (2016)

Percutaneous treatment of spontaneous left main coronary artery dissection using drug-eluting stent
por: Graidis, Christos, et al.
Publicado: (2014)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Hu, Mengjin, et al.
Publicado: (2022)

The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study
por: Morteza, Safi, et al.
Publicado: (2018)

Comparison between the Outcomes of Using Biodegradable-Polymer Drug-Eluting Stents and Those of Using Durable-Polymer Drug-Eluting Stents in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
por: Fawzy, Abd-Allah Y., et al.
Publicado: (2019)

Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease
por: Naito, Ryo, et al.
Publicado: (2015)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
por: Lin, Xiao Long, et al.
Publicado: (2022)

A rare complication of percutaneous coronary intervention: Coronary pseudoaneurysm formation
por: Çelik, Oğuzhan, et al.
Publicado: (2017)

How to overcome cardiovascular challenges in COVID-19 patients: a guide for common practice
por: Eslami, Pegah, et al.
Publicado: (2020)

Diffuse Long Coronary Artery Disease is Still an Obstacle for Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era?
por: Oh, Pyung Chun, et al.
Publicado: (2019)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Head-to-Head Comparison of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies
por: Zhang, Xinlin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fa1cup07f2a53fbftbibt38fp2